Gene · 1871
Papers3,808
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,808
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas. | Acta Neuropathol | 2023 | 37093270 | PubTator, text mining | PubMed |
Analysis of differential gene immune infiltration and clinical characteristics of skin cutaneous melanoma based on systems biology and drug repositioning methods to identify drug candidates for skin cutaneous melanoma. | Naunyn Schmiedebergs Arch Pharmacol | 2023 | 37086280 | PubTator, text mining | PubMed |
| HOOK1 Inhibits the Progression of Renal Cell Carcinoma via TGF-β and TNFSF13B/VEGF-A Axis. | Adv Sci (Weinh) | 2023 | 37085921 | PubTator, text mining | PubMed |
| Noncoding RNAs in asthmatic airway smooth muscle cells. | Eur Respir Rev | 2023 | 37076176 | PubTator, text mining | PubMed |
| ZBTB7A as a novel vulnerability in neuroendocrine prostate cancer. | Front Endocrinol (Lausanne) | 2023 | 37065756 | PubTator, text mining | PubMed |
| The regulatory role of microRNAs in common eye diseases: A brief review. | Front Genet | 2023 | 37065488 | PubTator, text mining | PubMed |
| Understanding the roles and regulation patterns of circRNA on its host gene in tumorigenesis and tumor progression. | J Exp Clin Cancer Res | 2023 | 37060016 | PubTator, text mining | PubMed |
| The progress of microenvironment-targeted therapies in brain metastases. | Front Mol Biosci | 2023 | 37056723 | PubTator, text mining | PubMed |
| Long noncoding RNA SNHG15: A promising target in human cancers. | Front Oncol | 2023 | 37056344 | PubTator, text mining | PubMed |
| Long noncoding RNA POU6F2-AS2 contributes to the aggressiveness of nonsmall-cell lung cancer via microRNA-125b-5p-mediated E2F3 upregulation. | Aging (Albany NY) | 2023 | 37053020 | PubTator, text mining | PubMed |
| LncRNA TCONS_00323213 Promotes Myogenic Differentiation by Interacting with PKNOX2 to Upregulate MyoG in Porcine Satellite Cells. | Int J Mol Sci | 2023 | 37047747 | PubTator, text mining | PubMed |
| CDK12/13 promote splicing of proximal introns by enhancing the interaction between RNA polymerase II and the splicing factor SF3B1. | Nucleic Acids Res | 2023 | 37026485 | PubTator, text mining | PubMed |
| Importance of long non-coding RNAs in the pathogenesis, diagnosis, and treatment of prostate cancer. | Front Oncol | 2023 | 37025585 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| Prognostic implication of heterogeneity and trajectory progression induced by enzalutamide in prostate cancer. | Front Endocrinol (Lausanne) | 2023 | 37008945 | PubTator, text mining | PubMed |
| Shared miRNA landscapes of COVID-19 and neurodegeneration confirm neuroinflammation as an important overlapping feature. | Front Mol Neurosci | 2023 | 37008787 | PubTator, text mining | PubMed |
| SIV Infection Regulates Compartmentalization of Circulating Blood Plasma miRNAs within Extracellular Vesicles (EVs) and Extracellular Condensates (ECs) and Decreases EV-Associated miRNA-128. | Viruses | 2023 | 36992331 | PubTator, text mining | PubMed |
| New Drugs and Therapies in Pulmonary Arterial Hypertension. | Int J Mol Sci | 2023 | 36982922 | PubTator, text mining | PubMed |
| Quercetin and Its Fermented Extract as a Potential Inhibitor of Bisphenol A-Exposed HT-29 Colon Cancer Cells' Viability. | Int J Mol Sci | 2023 | 36982678 | PubTator, text mining | PubMed |
| MYCN Amplification, along with Wild-Type RB1 Expression, Enhances CDK4/6 Inhibitors' Efficacy in Neuroblastoma Cells. | Int J Mol Sci | 2023 | 36982482 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1871/papers?page=17